| Product Code: ETC9953196 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Quinolones Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Quinolones Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Quinolones Market - Industry Life Cycle |
3.4 United Kingdom (UK) Quinolones Market - Porter's Five Forces |
3.5 United Kingdom (UK) Quinolones Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 United Kingdom (UK) Quinolones Market Revenues & Volume Share, By Pathogen Type, 2021 & 2031F |
3.7 United Kingdom (UK) Quinolones Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 United Kingdom (UK) Quinolones Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United Kingdom (UK) Quinolones Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 United Kingdom (UK) Quinolones Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Quinolones Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in the UK |
4.2.2 Growing awareness about the effectiveness of quinolones in treating various infections |
4.2.3 Rising demand for antibiotics due to increasing healthcare expenditure in the UK |
4.3 Market Restraints |
4.3.1 Concerns over antibiotic resistance leading to decreased effectiveness of quinolones |
4.3.2 Stringent regulations and guidelines on the use of antibiotics in the UK |
4.3.3 Competition from alternative antibiotic classes impacting the market growth |
5 United Kingdom (UK) Quinolones Market Trends |
6 United Kingdom (UK) Quinolones Market, By Types |
6.1 United Kingdom (UK) Quinolones Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Quinolones Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Quinolones Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 United Kingdom (UK) Quinolones Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 United Kingdom (UK) Quinolones Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 United Kingdom (UK) Quinolones Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.2 United Kingdom (UK) Quinolones Market, By Pathogen Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Quinolones Market Revenues & Volume, By Gram-Positive Pathogen, 2021- 2031F |
6.2.3 United Kingdom (UK) Quinolones Market Revenues & Volume, By Gram-Negative Pathogen, 2021- 2031F |
6.3 United Kingdom (UK) Quinolones Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Quinolones Market Revenues & Volume, By Lomefloxacin, 2021- 2031F |
6.3.3 United Kingdom (UK) Quinolones Market Revenues & Volume, By Gatifloxacin, 2021- 2031F |
6.3.4 United Kingdom (UK) Quinolones Market Revenues & Volume, By Norfloxacin, 2021- 2031F |
6.3.5 United Kingdom (UK) Quinolones Market Revenues & Volume, By Moxifloxacin, 2021- 2031F |
6.3.6 United Kingdom (UK) Quinolones Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.4 United Kingdom (UK) Quinolones Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Quinolones Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United Kingdom (UK) Quinolones Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 United Kingdom (UK) Quinolones Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Quinolones Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United Kingdom (UK) Quinolones Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 United Kingdom (UK) Quinolones Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 United Kingdom (UK) Quinolones Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Quinolones Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United Kingdom (UK) Quinolones Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 United Kingdom (UK) Quinolones Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Quinolones Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Quinolones Market Export to Major Countries |
7.2 United Kingdom (UK) Quinolones Market Imports from Major Countries |
8 United Kingdom (UK) Quinolones Market Key Performance Indicators |
8.1 Antibiotic prescription rates in the UK healthcare system |
8.2 Rate of bacterial infections in the UK population |
8.3 Research and development investments in new quinolone formulations |
8.4 Patient adherence to quinolone treatment regimens |
8.5 Number of reported cases of antibiotic-resistant infections in the UK |
9 United Kingdom (UK) Quinolones Market - Opportunity Assessment |
9.1 United Kingdom (UK) Quinolones Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 United Kingdom (UK) Quinolones Market Opportunity Assessment, By Pathogen Type, 2021 & 2031F |
9.3 United Kingdom (UK) Quinolones Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 United Kingdom (UK) Quinolones Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United Kingdom (UK) Quinolones Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 United Kingdom (UK) Quinolones Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Quinolones Market - Competitive Landscape |
10.1 United Kingdom (UK) Quinolones Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Quinolones Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here